Patients with symptomatic (New York Heart Association [NYHA] class III or IV) systolic (left ventricular ejection fraction [LVEF] ≤40%) congestive heart failure (CHF) were randomized to ...
Explore how deep learning enables automated extraction of NYHA classes and heart failure symptoms, enhancing heart failure ...
In this randomized controlled trial of patients with heart failure and mildly decreased or preserved ejection fraction, ...
The preliminary data open the door to an alternative approach to invasive monitoring in heart failure patients.
Additionally, 92% of patients either improved or maintained their New York Heart Association (NYHA) class, a key metric for ...
1d
Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback